Top 15 Questions and Answers. EU FMD Safety Features and Verification

Size: px
Start display at page:

Download "Top 15 Questions and Answers. EU FMD Safety Features and Verification"

Transcription

1 Top 15 Questions and Answers EU FMD Safety Features and Verification

2 Now set for early 2019, the Delegated Act on safety features for the European Union (EU) Falsified Medicines Directive (FMD) has pharmaceutical companies, parallel importers, wholesalers, and pharmacies facing a tight timeline to address extensive serialisation, compliance reporting, and verification requirements. The Delegated Act includes several unexpected rules that add complexity to FMD planning and preparation. Many supply chain companies have raised questions related to the impending Delegated Act requirements. Read on for some of the most common queries, plus answers from TraceLink experts. 2

3 Questions 1. What is the likelihood that all supply-chain organisations will be prepared by the February 9, 2019, deadline? What is the sense of readiness within the pharmaceutical industry? 2. Could you elaborate on the reporting in compliance reporting? 3. What are the safety features and how are they supposed to be verified? 4. Do all medicinal products require a serial number and other safety features? 5. Do the EU FMD regulations cover only European Union member states? If I m selling into a specific country, how do I know if that country is covered or not? 6. Can anybody submit compliance reporting to the European hub? 7. The European Federation of Pharmaceutical Industries and Associations (EFPIA) model explains that wholesalers may perform voluntary verification, but there are certain situations where a wholesaler is required to verify product identity. Why is there a difference? 8. If a distribution warehouse drops a shipper case of product that must be destroyed, who decommissions the serial number on the product units in that shipper case the MAH or the warehouse? 9. Suppose I buy products from a wholesaler in Country A, store them in Country B, with plans to resell them later to Country C for repackaging or relabeling. Where does decommissioning of the original barcode take place? 10. When a wholesaler is expected to perform risk-based verification of products against a national repository, are they expected to scan and verify each and every package? Does this thereby present an argument for aggregation in these instances? 11. The EU reporting and verification model requires that parallel distributors must verify against national repositories. Shouldn t it be possible to do this verification using the European hub? 12. What is the regulatory view for track and trace for medical devices? 13. Do veterinary medicinal products require safety features? 14. How can TraceLink help my company meet the EU FMD requirements? 15. What enterprise resource planning (ERP) systems does TraceLink already support? 3

4 Question 1: What is the likelihood that all supply-chain organisations will be prepared by the February 9, 2019, deadline? What is the sense of readiness within the pharmaceutical industry? Answer: There is a lot to do for the hundreds of thousands of supply chain members serving the EU market in order to be ready within the next two years. Each company faces considerable work both internally and across their supply network to prepare, and the decisions that you make will be dependent on the decisions that others in your supply network make. But there are clear ways of reducing time, cost, and risk during this period. Many companies are already in the process of developing a clear strategy for surveying product lines, internal packaging sites, and external supply partners to determine the data management and network connectivity scope they need to master. Two years may seem like a lot of preparation time. But if you wait to create a full serialisation and compliance plan with resource requirements and realistic timelines, you introduce significant risk. Use the lead time you have to your advantage in order to determine the full scale and scope of your business requirements and the key solution capabilities and resources that you ll need for success. Question 2: Could you elaborate on the reporting in compliance reporting? Answer: Full compliance with any track and trace regulation typically has many parts. Depending on the regulation, this may include activities such as serialisation, verification, supply chain traceability and government reporting. Reporting in terms of EU FMD compliance for a marketing authorisation holder (MAH) goes well beyond simply executing a file submission to a governmental system. For the EU, compliance reporting involves a multitude of activities including: The collection and preparation of product master data. The collection and preparation of serialised product pack data. An understanding of the business rules governing each target market for each product shipped into the market. 4

5 Generation and submission of the appropriate product master data and pack data transactions through an approved communication link to the European hub. Management of product status with the European hub as that status changes throughout the life cycle of the product (such as decommission or recall). Management of exceptions as they may occur (such as submission errors). Secure regulatory compliance with the EU FMD demands a complete compliance management solution that supports all facets of compliance reporting to the European hub. Question 3 : What are the safety features and how are they supposed to be verified? Answer: Safety features contain two parts related to the packaging and identification of a medicinal product: 1. A unique identifier encoded in a two-dimensional barcode, which enables the identification and verification of each pack. The unique identifier contains multiple data elements, including a product code and unique serial number. To verify the unique identifier, a stakeholder (dispenser or other) in the supply chain scans the barcode and submits the information to the national repository. The national repository responds with information confirming the authenticity of the unique identifier. 2. Anti-tampering technologies that enable the determination of whether the product packaging has been tampered with. There is no mandatory specification for what anti-tampering devices must be included on a pack. Question 4: Do all medicinal products require a serial number and other safety features? Answer: Not all medicinal products require safety features. The requirement depends on whether the product is a prescription drug or not, as well as the risk level associated with the product. 5

6 In general, all medicines requiring a prescription must carry a serial number and other safety features, with the following exceptions: Prescription drugs listed in Annex I of the Delegated Act (the whitelist ) are exempt from this requirement. Medicinal products that are not subject to prescription, but are listed in Annex II of the Delegated Act (the blacklist ) because of their risk level, do require safety features applied to each pack. It is important to note that a product may be considered a prescription medicine in one country but not in another. Thus, in preparing your serialisation and compliance system to manage multi-market products, such a system will need to identify and act appropriately (for example, in applying safety features) depending on the target market. Question 5: Do the EU FMD regulations cover only European Union member states? If I m selling into a specific country, how do I know if that country is covered or not? Answer: The EU FMD and related Delegated Acts were designed by the European Parliament and EU regulators to provide a harmonised European Medicines Verification System (EMVS) for adoption across EU member states. Other countries having extensive trade arrangements with the EU that are expected to align with and follow EU FMD requirements for safety features include Switzerland and the European Economic Area members of Norway, Iceland, and Liechtenstein. It is also important to note that the EU FMD provides considerable flexibility to the individual country to determine if a medicine must contain safety features such as an identifier and on-package features (and thus require serialisation/reporting) or not. In addition, a given country may add additional data to the on-package and data carrier requirements. So the same drug product may have quite different serialisation and reporting requirements in two different target markets. 6

7 Question 6: Can anybody submit compliance reporting to the European hub? Answer: Connections to the European hub are managed by the European Medicines Verification Organisation (EMVO). The EMVO have very specific criteria for how a connection is developed and proven. Question 7: The European Federation of Pharmaceutical Industries and Associations (EFPIA) model explains that wholesalers may perform voluntary verification, but there are certain situations where a wholesaler is required to verify product identity. Why is there a difference? Answer: Early on, the EFPIA took the lead in coming up with a model for a repositories system of drug product information and serialisation data coupled with verification of drug products in the EU, which then became the European Stakeholder Model (ESM). In this original design, it stipulated that while pharmacy dispensers would be required to verify drug product identity, wholesalers in the middle of the supply chain would also be able to verify identity of drug products using similar mechanisms if so desired and on a voluntary basis. With the publication of the final Delegated Act related to safety features and the repositories system, however, several supply chain transactions were identified as areas where potential risk was introduced into the supply chain. These included sales between wholesale distributors in the supply chain and resale of returned product. As a result, certain supply-chain scenarios involving wholesale distributors now trigger required risk-based verification procedures. For example, if a wholesale distributor purchased drug product from another wholesale distributor that is not the original manufacturer a wholesaler holding market authorisation or a wholesaler that is essentially designated as an agent of the MAH this second wholesale distributor is required to verify the authenticity of the unique identifier prior to resale. 7

8 Question 8: If a distribution warehouse drops a shipper case of product that must be destroyed, who decommissions the serial number on the product units in that shipper case the MAH or the warehouse? Answer: If a case of product is dropped and it is determined that all units in the case must be destroyed, then the serial numbers assigned to it must be destroyed. But whether the case must be decommissioned or not depends on whether the unsaleable product has been commissioned and reported to the EMVS. If the MAH owns the product, then it has already been commissioned and the serial number will need to be decommissioned. If the distribution warehouse has not reported product master data to the EMVS, however, then decommissioning is not required since no original commission report was generated. The warehouse may still want to report it for internal bookkeeping purposes, though. Question 9 : Suppose I buy products from a wholesaler in Country A, store them in Country B, with plans to resell them later to Country C for repackaging or relabeling. Where does decommissioning of the original barcode take place? Answer: If the repackaging and relabeling occurs in Country C, then the decommissioning would occur in Country C prior to the repackaging or relabeling of the original pack. The key point is determining when the repackaging or relabeling occurs not necessarily where it occurs. 8

9 Question 10: When a wholesaler is expected to perform risk-based verification of products against a national repository, are they expected to scan and verify each and every package? Does this thereby present an argument for aggregation in these instances? Answer: Unique identity is defined at the package level under the EU FMD. Since the risk-based verification requirement specifies that the wholesaler shall verify the authenticity of the unique identifier of the medicinal product, the common industry interpretation we hear is that the wholesaler will need to verify each package. If you receive a case of 50 packages in a scenario that triggers the verification requirement, then you will need to perform verification on those individual packs regardless of the case packing that they were sent in. What is unclear is any specific requirement that determines the precise method that a company may use to perform that verification. The Delegated Act on safety features does not specifically state that each individual barcode of a pack must be physically scanned as part of the verification process for each unique identifier. This may open the door for the use of inference and aggregation to improve the speed of the verification process. If the packages are contained in a closed case for which a case identifier has been created and aggregation relationships generated between the case identifier and the identifiers of each of the packs within the case, then there are potential benefits in being able to infer the contents of that closed case using aggregation data to retrieve the unique serial numbers needed for verification. This would allow the wholesaler to avoid having to open the case, extract each pack, and then individually scan each pack for verification against the repositories system. Note that caselevel serialisation and aggregation are not required by law under the EU FMD and associated Delegated Act on safety features and aggregation itself is the subject of considerable industry debate. These are just potential operational enhancements that the industry may consider during implementation of solutions to efficiently manage EU FMD compliance across the supply network. 9

10 Question 11: The EU reporting and verification model requires that parallel distributors must verify against national repositories. Shouldn t it be possible to do this verification using the European hub? Answer: The EMVS, which includes the European hub and a series of national repositories, is structured such that when an MAH reports product master data and pack data to the European hub, it passes the pack and unique identifier information straight through to the national repositories. The national repositories are the actual repositories containing the required package data and unique identifier for verification within member states. The European hub is not a repository in this sense. You can think of the European hub more like a switch or central information and data router. The system was really designed for stakeholders to query against the local system that actually has the information needed for verification. Question 12: What is the regulatory view for track and trace for medical devices? Answer: The EU FMD only covers medicinal products for human use and doesn t address the identification and traceability of medical devices. Globally, regulations concerning unique device identity (UDI) have been considered or adopted across several countries. Countries such as the U.S., Argentina, and Turkey already have regulations concerning UDI while places such as the EU and China are considering them. Because we ve seen serialisation regulations and the track and trace of prescription medicines grow so quickly in this decade, it wouldn t be surprising to witness significant growth in similar requirements for medical devices in the future. Probably the biggest difference is that medical device regulations tend to focus on UDI and not on supply-chain traceability. Question 13: Do veterinary medicinal products require safety features? Answer: No. Safety features are only required for products intended for human use. 10

11 Question 14: How can TraceLink help my company meet the EU FMD requirements? Answer: It is crucial to start planning for the extensive new serialisation requirements in order to meet the 2019 deadline for EU FMD compliance. This is where TraceLink can help. Working with our proven, global network-tenant solution allows you to leverage an end-to-end compliance platform that is already commercially deployed to meet EU FMD serialisation and compliance reporting requirements, while simplifying the overall management of your supply network. The TraceLink EU Compliance solution was designed to provide exactly that a complete compliance management solution, including: Preparation and submission of required product master data and serialised pack data. Management and updating of product status. Automated report triggering based on master data and operational workflow triggers. Full exception management and alerting. Full search capabilities based on flexible criteria. Report drilldown for targeted data retrieval. Question 15: What enterprise resource planning (ERP) systems does TraceLink already support? Answer: TraceLink supports native integration with a broad range of ERP and warehouse management (WMS) systems, including SAP, Oracle, JDE, Microsoft, QAD, Infor, and JDA. In addition, TraceLink has integrations with more than a dozen of the leading line management systems such as Optel Vision, Systech, Laetus, Uhlmann, and MTPCE. TraceLink also speeds connectivity to any new systems with a well-defined integration interface and transaction mapping process. Finally, solutions on the TraceLink Life Sciences Cloud also support standalone operation using our efficient user interface and manual data import capabilities for those companies not yet ready to implement a fully integrated infrastructure. 11

12 Additional Resources TraceLink has a very detailed EU FMD educational webinar on the track and trace requirements. Held live on February 3, this webinar is available on-demand. Get help as you begin the detailed planning required for successful EU FMD compliance. The Delegated Act on safety features detailing implementation requirements was published in the Official Journal of the European Union on February 9, The regulation is available here. The European Commission published an additional set of questions and answers on safety features for medicinal products here. 12

13 To learn more about TraceLink s EU solutions, contact us. REQUEST AN EU SOLUTIONS DEMO

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update 19 th February 2016 EMA London Falsified Medicines February 9 th 2016 Delegated Regulation (EU) 2016/161

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU

More information

The Blueprint approach

The Blueprint approach the way to comply with FMD and its Delegated Regulation: The Blueprint approach Johan Verhaeghe (FMD Project Manager) Frankfurt, 16 February 2016 EGA Vision 2020 To provide sustainable access to high quality

More information

Project responsibilities

Project responsibilities Project responsibilities Tallinn November 24th, 2017 Our Mission Falsified / counterfeit medicines are a serious risk for the citizens all around the world New legislation published on the 9th February

More information

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical

More information

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Global Developments and the Need for Convergence Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Developments across the world Regulatory bodies need to address Public Health issues one

More information

European Medicines Verification Organisation: Requirements for the European Medicines Verification System URS Lite

European Medicines Verification Organisation: Requirements for the European Medicines Verification System URS Lite EMVO_0020 3.0 7/3/2017 1 of 51 European Medicines Verification Organisation: Requirements for the European Medicines Verification System URS Lite Copyright 2017 EMVO All rights reserved. Reproduction in

More information

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day FMD Implementation challenges for the manufacturers Joan Cahill, Pfizer 28 th March 2017 FMD Implementation Challenges Industry Perspective Joan

More information

Health systems and products Medical products quality, safety and innovation VERSION 8

Health systems and products Medical products quality, safety and innovation VERSION 8 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medical products quality, safety and innovation SAFETY FEATURES FOR MEDICINAL PRODUCTS FOR HUMAN USE QUESTIONS

More information

The role of the European Commission during the FMD implementation phase Agnès Mathieu DG SANTE European Commission

The role of the European Commission during the FMD implementation phase Agnès Mathieu DG SANTE European Commission The role of the European Commission during the FMD implementation phase Agnès Mathieu DG SANTE European Commission 1st EMVO-MS Workshop 13 December 2016 Delegated Regulation on the Safety Features Adoption

More information

Serialisation End User View

Serialisation End User View Serialisation End User View Agenda What is serialisation? Why do we serialise? Regulatory landscape and challenges Approaches to serialisation WHAT IS SERIALISATION? Packaging Levels Lowest saleable unit

More information

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,

More information

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Table of Contents Serialization and epedigree: Current Direction... 3 Why Invest in Serialization?... 3 What Tasks do Life

More information

Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies

Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies White Paper www.nicelabel.com/pharma 1 1 Executive summary The number of challenges for the

More information

HDA DSCSA 2019 Compliance Scenarios

HDA DSCSA 2019 Compliance Scenarios HDA DSCSA 2019 Compliance Scenarios DSCSA Overview and Milestone Timeline The Drug Supply Chain Security Act (DSCSA) takes effect over a 10 year period (from 2013 to 2023) and is punctuated by requirement

More information

MAHs and CMOs considerations and objectives to meet upcoming regulations in 2019

MAHs and CMOs considerations and objectives to meet upcoming regulations in 2019 ARVATO SYSTEMS MAHs and CMOs considerations and objectives to meet upcoming regulations in 2019 Pascal Leppich, Arvato Systems Joseph Tshimbalanga, Systec & Services Abcoude, 22 June 2017 The WINDOW is

More information

Process and Architecture Overview IDMP Identification of Medicinal Products. Sven Eller, Life Sciences Solution Engagement Manager

Process and Architecture Overview IDMP Identification of Medicinal Products. Sven Eller, Life Sciences Solution Engagement Manager Process and Architecture Overview IDMP Identification of Medicinal Products Sven Eller, Life Sciences Solution Engagement Manager Legal Disclaimer The information in this document is confidential and proprietary

More information

How Much Will Serialization Really Cost? AN INTRODUCTION TO THE TOTAL COST OF OWNERSHIP

How Much Will Serialization Really Cost? AN INTRODUCTION TO THE TOTAL COST OF OWNERSHIP How Much Will Serialization Really Cost? AN INTRODUCTION TO THE TOTAL COST OF OWNERSHIP TABLE OF CONTENTS Introduction Breaking down the whole iceberg What is Total Cost of Ownership? Acquisition is Just

More information

Corporate Presentation & Offer for SAP ATTP December 2015

Corporate Presentation & Offer for SAP ATTP December 2015 Corporate Presentation & Offer for SAP ATTP December 2015 Page : 1 Page : 2 Content Our Vision Our Company Business Challenges SAP Advanced Track and Trace for Pharmaceuticals (ATTP) Our Offer Our Vision

More information

GS1 Guide on Unique Device Identification (UDI) implementation

GS1 Guide on Unique Device Identification (UDI) implementation GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.

More information

National Blueprint System Slovakia Kick-Off Meeting

National Blueprint System Slovakia Kick-Off Meeting National Blueprint System Slovakia Kick-Off Meeting Bratislava November 22th, 2017 Nov. 22th, 2017 Kick-Off SOOL 1 Agenda Arvato Architecture NMVS Web Service Interface Roles and Rights Onboarding Project

More information

STATUS REPORT Status of the project to implement the Falsified Medicines Directive

STATUS REPORT Status of the project to implement the Falsified Medicines Directive STATUS REPORT 2017 Status of the project to implement the Falsified Medicines Directive 2 www.securpharm.de About securpharm e.v. securpharm e.v. is a nonprofit stakeholder organisation that develops the

More information

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Healthcare Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Release 1.0, May 23 2017 Table of Contents 1 Introduction... 7 2 IDENTIFY: Questions about GS1

More information

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within

More information

EVALUATE LABELING SYSTEM? IS IT TIME TO YOUR A GUIDE TO CHANGE MANAGEMENT

EVALUATE LABELING SYSTEM? IS IT TIME TO YOUR A GUIDE TO CHANGE MANAGEMENT IS IT TIME TO EVALUATE YOUR LABELING SYSTEM? A GUIDE TO CHANGE MANAGEMENT F O R H E A LT H C A R E TEKLYNX Americas 409 E. Silver Spring Drive Suite U12 Whitefish Bay, WI 53217 USA WWW.TEKLYNX.COM Tel:

More information

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) Impressions Kaiseraugst A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) SETRM2016 Rastreabilidade de Medicamento Sao Paulo, Jun 2016 Agenda Worldwide,

More information

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion

More information

EMVO ON-BOARDING HOW TO CONNECT TO THE EU HUB? VERSION OCTOBER 2017

EMVO ON-BOARDING HOW TO CONNECT TO THE EU HUB? VERSION OCTOBER 2017 EMVO ON-BOARDING HOW TO CONNECT TO THE EU HUB? VERSION5.0 18 OCTOBER 2017 www.emvo-medicines.eu helpdesk@emvo-medicines.eu Please check www.emvo-medicines.eu for the latest version of this presentation

More information

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION Serialization a global approach Emanuele Tellaroli Key Account Manager ANTARES VISION Beirut 02 June 2016 Serialization concept THE SMALLEST ITEM PUT ON SALE (selling unit) IS IDENTIFIED BY THE COMBINATION

More information

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance

More information

Falsified Medicines Directive Info session for MAHs

Falsified Medicines Directive Info session for MAHs Falsified Medicines Directive Info session for MAHs 25/4/2017 14u 17u Auditorium at Wolubilis Agenda Welcome MAH responsibilities in FMD Products to market Q&A Interaction with the Verification system

More information

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS Pedro Ferreira ANF What are falsified medicines? Growing threat to public health and safety in Europe Counterfeit medicines seized

More information

NMVO on-boarding presentation

NMVO on-boarding presentation NMVO on-boarding presentation Please check https://www.emvo-medicines.eu/ for the latest version of this presentation and the on-boarding guideline. European Medicines Verification Organisation (EMVO)

More information

Brexit Guidance for Stakeholders Human and veterinary medicines

Brexit Guidance for Stakeholders Human and veterinary medicines Brexit Guidance for Stakeholders Human and veterinary medicines DATE: 03 JANUARY 2018 V.2 This guide does not purport to be an interpretation of law and/or regulations. The content provided is subject

More information

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide Romania Raluca Vasilescu Cabinet M Oproiu Pharmaceutical Trademarks 2015/2016 A Global Guide Romania Cabinet M Oproiu Author Raluca Vasilescu Selection, clearance and registration In Romania, pharmaceutical

More information

Pharmacovigilance: Information systems and services

Pharmacovigilance: Information systems and services Pharmacovigilance: Information systems and services Supporting business activities of the revised pharmacovigilance legislation through better information systems An agency of the European Union To deliver

More information

Vnr. Nordic Article Number. Instruction booklet Version: 1.7 1/23

Vnr. Nordic Article Number. Instruction booklet Version: 1.7 1/23 Vnr Nordic Article Number Instruction booklet Version 1.7 2017-05-10 Version: 1.7 1/23 History Date Version Comment Author 2013-03-25 1.0 New document Hans Andersson 2014-01-22 1.1 Changed names from Apotekens

More information

STATUS REPORT Status of the project to implement the Falsified Medicines Directive

STATUS REPORT Status of the project to implement the Falsified Medicines Directive STATUS REPORT 2018 Status of the project to implement the Falsified Medicines Directive 2 About securpharm e.v. securpharm e.v. is a nonprofit stakeholder organisation that develops the authentication

More information

Implementation of Articles 15 and 16 of the Tobacco Products Directive Brussels 12 October 2017

Implementation of Articles 15 and 16 of the Tobacco Products Directive Brussels 12 October 2017 Implementation of Articles 15 and 16 of the Tobacco Products Directive Brussels 12 October 2017 Please note that any views expressed in this presentation may in no way be regarded as stating an official

More information

ASK THE EXPERTS GS1 DataMatrix

ASK THE EXPERTS GS1 DataMatrix ASK THE EXPERTS GS1 DataMatrix The Basics and an Example Implementation GS1 Healthcare Conference Budapest 21 October 2015 Ask the Experts GS1 DataMatrix Today s presenters GS1 DataMatrix The Basics -

More information

SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM?

SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM? SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM? B U S I N E S S T R A N S F O R M AT I O N T H R O U G H T O TA L S Y S T E M I N T E G R AT I O N TEKLYNX Americas

More information

Laetus Track & Trace Solution

Laetus Track & Trace Solution Laetus Track & Trace Solution 16/10/2017 Marcia Erdelyi ERTEC 16/10/2017 Agenda 1. Introduction Laetus 2. Solution portfolio 3. Laetus Secure Track & Trace 4. Project management & service concept 5. Track

More information

GS1 standards for unique identification of medicinal products

GS1 standards for unique identification of medicinal products GS1 standards for unique identification of medicinal products Lisbon, Portugal 3 July 2013 Silverio Paixão, Chief Innovation & Standards Officier, GS1 Portugal Who is GS1? GS1 a neutral, not-for-profit,

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

Saudi Drug Code (SDC), and Drug Barcoding Specifications

Saudi Drug Code (SDC), and Drug Barcoding Specifications Drug Sector Licensing Executive Directorate Guidance for Industry Saudi Drug Code (SDC), and Drug Barcoding Specifications This document outlines the SDC and the new drug barcode requirements for pharmaceuticals.

More information

Pharmacy Chain Cuts Order Turnaround Time in Half with Mobile RFID Workflow Solution

Pharmacy Chain Cuts Order Turnaround Time in Half with Mobile RFID Workflow Solution Microsoft BizTalk Server Customer Solution Case Study Pharmacy Chain Cuts Order Turnaround Time in Half with Mobile RFID Workflow Solution Overview Country or Region: India Industry: Pharmaceuticals Customer

More information

SUPPLY CHAIN VISIBILITY AND CONTROL SOLUTIONS

SUPPLY CHAIN VISIBILITY AND CONTROL SOLUTIONS SUPPLY CHAIN VISIBILITY AND CONTROL SOLUTIONS Acsis Platform and the Key to Success Acsis provides supply chain traceability solutions that include data capture, serialization, label management and ERP

More information

GS1 Healthcare Newsletter

GS1 Healthcare Newsletter No. 25 Q4 2012 table of contents Special feature: GS1 Healthcare Conference Gathers in Lisbon 1 GS1 Healthcare takes the stage in Lisbon 1 McKinsey & Company reports on the benefits a single global standard

More information

Enabling Asset Integrity Management for the Oil & Gas Industry

Enabling Asset Integrity Management for the Oil & Gas Industry Enabling Asset Integrity Management for the Oil & Gas Industry THE CHALLENGE Ensuring operational integrity of critical assets and installations is of paramount importance to oil field operators and the

More information

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae Welcome to our 29 th Global GS1 Healthcare Conference Follow us on Twitter and tweet about the conference! @GS1Healthcare #GS1HCuae Welcome to the conference 29 th Global GS1 Healthcare Conference Dubai,

More information

Presse-Information Press release Information de presse

Presse-Information Press release Information de presse Presse-Information Press release Information de presse Kontakt/Contact: Dr. Kathrin Rübberdt Tel. ++49 (0) 69 / 75 64-2 77 Fax ++49 (0) 69 / 75 64-2 72 e-mail: presse@dechema.de Trend Report February 2018

More information

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where

More information

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

Infor Distribution SX.e

Infor Distribution SX.e Distribution Infor Distribution SX.e Deliver more With a constantly shifting business landscape and growing competition from e-tailors, you need to deliver more than what has been traditionally expected

More information

HDA Qs and As on the Drug Supply Chain Security Act (DSCSA) VERSION 4.0 June 2016

HDA Qs and As on the Drug Supply Chain Security Act (DSCSA) VERSION 4.0 June 2016 (DSCSA) This document, the HDA Qs and As on the Drug Supply Chain Security Act (DSCSA), has been prepared by the Healthcare Distribution Alliance (HDA) in consultation with its Traceability Implementation

More information

UDI: From Compliance to Value OMTEC June 2013 Karen Conway

UDI: From Compliance to Value OMTEC June 2013 Karen Conway UDI: From Compliance to Value OMTEC June 2013 Karen Conway 1 GHX GHX proprietary information: Please do not not copy copy or or distribute UDI: The Reality UDI: The Reality UDI: The Reality UDI: The Reality

More information

Unique Device Identification (UDI)

Unique Device Identification (UDI) Unique Device Identification (UDI) How GS1 standards can help you comply with UDI regulations Supported by Medical device suppliers and manufacturers do you comply with UDI? If you supply medical devices

More information

Single Euro Payments Area

Single Euro Payments Area Single Euro Payments Area Background The Single Euro Payments Area (SEPA) is a payment-integration initiative of the European Union for simplification of bank transfers. As of March 2012, SEPA consists

More information

proalpha ERP CAD Integration ERP for SMEs

proalpha ERP CAD Integration ERP for SMEs proalpha ERP CAD Integration ERP for SMEs proalpha CA-Link creates a consistent data and information flow between engineering and proalpha ERP. The highlights of proalpha CA-Link: Your CAD software and

More information

THE CASE FOR ERP AND TMS INTEGRATION 4 REASONS WHY ERP FAILS TRANSPORTATION MANAGEMENT

THE CASE FOR ERP AND TMS INTEGRATION 4 REASONS WHY ERP FAILS TRANSPORTATION MANAGEMENT WHITE PAPER THE CASE FOR ERP AND TMS INTEGRATION Discover why ERP systems continue to fail at delivering the value required for transportation management, and the four reasons why integrating a Transportation

More information

RFID Automation and Extensibility A Roadmap to RFID Integration on a SAP Centric Platform

RFID Automation and Extensibility A Roadmap to RFID Integration on a SAP Centric Platform RFID Automation and Extensibility A Roadmap to RFID Integration on a SAP Centric Platform Dave Perrine VP Marketing PEAK Technologies Dave Marzouk RFID Solution Director/Partner Management SAP Labs, LLC

More information

Information Management FAQ for UDI

Information Management FAQ for UDI White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and

More information

GS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System

GS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System GS1 Turkey Yeliz Geriş İTS -Turkish Pharmaceutical Track and Trace System What is İTS? İTS-Pharmaceutical Track & Trace System Project Phases Implementation Timeline Objectives Scope Labeling Workflow

More information

FOUR STRATEGIES. To allow you more time with patients

FOUR STRATEGIES. To allow you more time with patients FOUR STRATEGIES To allow you more time with patients Hearing care professionals spend years studying the science surrounding how people hear, the causes of hearing loss, how it can be treated and how it

More information

Membership Registration Form. Company Details

Membership Registration Form. Company Details Membership Registration Form This form allows you to become a voting or non-voting member of GS1 Healthcare, the global healthcare user group. GS1 Healthcare welcomes the following stakeholders as voting

More information

Cornerstone Solutions, Inc.

Cornerstone Solutions, Inc. Blueprint for Success Cornerstone Solutions, Inc. An implementation guide based on 50+ WMS Implementation Projects White Paper Introduction You know that implementing a WMS can increase your operation

More information

All NEMOs proposal for the price coupling algorithm and for the continuous trading matching algorithm, also incorporating TSO and NEMO proposals for

All NEMOs proposal for the price coupling algorithm and for the continuous trading matching algorithm, also incorporating TSO and NEMO proposals for All NEMOs proposal for the price coupling algorithm and for the continuous trading matching algorithm, also incorporating TSO and NEMO proposals for a common set of requirements, in accordance with Article

More information

UNDERSTANDING BARCODES

UNDERSTANDING BARCODES Start > UNDERSTANDING BARCODES & THE BENEFITS OF USING THEM Barcode Scanning Technology is able to help businesses raise warehouse productivity by offering unrivalled accuracy and efficiency within their

More information

Pharmaceutical RFID: From Mandates to Endorsements and Laws

Pharmaceutical RFID: From Mandates to Endorsements and Laws Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed

More information

Idea Management for SAP

Idea Management for SAP Idea Management for SAP The Challenges Corporations and public institutions are both facing the same drive to innovate today. Businesses must rise above costs of production to win against global competition.

More information

GIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers

GIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers GIRP comments on Guidelines on the principles of Good Distribution Practices for active substances for medicinal products for human use submitted for public consultation Introduction: GIRP, the European

More information

The implications of the new EU Medical Device Regulation on Combination Product Packaging

The implications of the new EU Medical Device Regulation on Combination Product Packaging The implications of the new EU Medical Device Regulation on Combination Product Packaging ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com A niche

More information

Traceability in the Crop Protection industry in Europe Presentation to the GS1 HUG conference,

Traceability in the Crop Protection industry in Europe Presentation to the GS1 HUG conference, Traceability in the Crop Protection industry in Europe Presentation to the GS1 HUG conference, 23.3.2006 Content About our Supply Chain The structure of our products Tracking and tracing The FAO code of

More information

ENCODING, PRINTING & VALIDATING RFID TAGS WITH PORTALTRACK

ENCODING, PRINTING & VALIDATING RFID TAGS WITH PORTALTRACK ENCODING, PRINTING & VALIDATING RFID TAGS WITH PORTALTRACK Maximizing Your RFID Investment with PortalTrack from MSM Solutions MSM Solutions PortalTrack gives you the freedom to tailor your RFID and Barcode

More information

The implications of the new EU Medical Device Regulation on Combination Product Packaging

The implications of the new EU Medical Device Regulation on Combination Product Packaging The implications of the new EU Medical Device Regulation on Combination Product Packaging June 2017 ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com

More information

Guide for Recall of Medicinal Products for Human and Veterinary Use

Guide for Recall of Medicinal Products for Human and Veterinary Use Guide for Recall of Medicinal Products for Human and Veterinary Use SUR-G0019-3 22 NOVEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes

More information

Primary Distribution Activities

Primary Distribution Activities Primary Distribution Activities Wholesale Distribution Information Day, Paul Sexton GMP Manager Date Insert on Master Slide Slide 1 Topics What is a Primary Distributor / Wholesaler Special Responsibilities

More information

Epicor for Distribution

Epicor for Distribution Epicor for Distribution As a distributor, you know that employing a powerful technology strategy is a key to success and to staying ahead of the competition, which seems to get more sophisticated every

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

Infor VISUAL. Introduction. Statement of direction

Infor VISUAL. Introduction. Statement of direction Statement of direction Infor VISUAL Introduction Infor VISUAL continues to change the way that manufacturers especially those who specialize in complex, make-to-order sales tackle the challenges of a global

More information

AUTOMATE YOUR SUPPLY CHAIN WITH MOBILE DATA COLLECTION SOFTWARE

AUTOMATE YOUR SUPPLY CHAIN WITH MOBILE DATA COLLECTION SOFTWARE RFgen Mobile Foundations for SAP AUTOMATE YOUR SUPPLY CHAIN WITH MOBILE DATA COLLECTION SOFTWARE REDUCE COST MAXIMIZE PRODUCTIVITY IMPROVE ACCURACY INCREASE EFFICIENCY SUPPLY CHAIN MANAGEMENT. FAST. ACCURATE.

More information

Auto-ID Enterprise Release Notes

Auto-ID Enterprise Release Notes AIE Auto-ID Enterprise Release Notes Copyright Copyright(c) 2007 SAP AG. All rights reserved. Neither this document nor any part of it may be copied or reproduced in any form or by any means or translated

More information

Business and Application Architecture

Business and Application Architecture Nordic Smart Government Report on Business and Application Architecture v.1.0.3 March 15, 2018 Table of contents 1 Introduction... 2 2 Scope and deliverables... 3 3 Summary... 3 4 Business and application

More information

Prescription Product Supplier Requirements

Prescription Product Supplier Requirements Prescription Product Supplier Requirements Prescription Product Suppliers: Prescription product suppliers are those suppliers that manufacture, package, or distribute a prescription pharmaceutical (drug)

More information

ION DIFFERENTIATION FLEXIBLE STANDARDS BASED MESSAGING BUS CONNECT APPLICATIONS IN A VARIETY OF WAYS CREATE MONITORS / ALERTS CREATE CUSTOM WORKFLOWS

ION DIFFERENTIATION FLEXIBLE STANDARDS BASED MESSAGING BUS CONNECT APPLICATIONS IN A VARIETY OF WAYS CREATE MONITORS / ALERTS CREATE CUSTOM WORKFLOWS ION DIFFERENTIATION FLEXIBLE STANDARDS BASED MESSAGING BUS CONNECT APPLICATIONS IN A VARIETY OF WAYS CREATE MONITORS / ALERTS CREATE CUSTOM WORKFLOWS ION PRACTICAL APPLICATION: INFOR APP TO INFOR APP INFOR

More information

Fourth Stakeholders forum on the implementation of the new Pharmacovigilance legislation

Fourth Stakeholders forum on the implementation of the new Pharmacovigilance legislation Fourth Stakeholders forum on the implementation of the new Pharmacovigilance legislation Module II - Pharmacovigilance system master file Presented by: Joanna Harper Inspections, Enforcement & Standards

More information

Barcodes on Unit of Use

Barcodes on Unit of Use Barcodes on Unit of Use 1 What hospitals need Hospitals need medications Ready-to-Administer In Unit-of-Use With Barcode 2 What hospitals need Ready-to-Administer If not, must go through additional pharmacy

More information

Transparency of the European Commission s expert groups: which fingerprints can be traced back?

Transparency of the European Commission s expert groups: which fingerprints can be traced back? Transparency of the European Commission s expert groups: which fingerprints can be traced back? By Andreia Silva, Farid Safi and José Antonio Campos Navarro, 20 June 2017 The Lisbon Treaty came as a surprise

More information

Supplier Assurance Program. CBE Pty Ltd

Supplier Assurance Program. CBE Pty Ltd Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.

More information

MSC Chain of Custody Standard: Default Version

MSC Chain of Custody Standard: Default Version CERTIFIED SUSTAINABLE SEAFOOD Marine Stewardship Council MSC Chain of Custody Standard: Default Version Version 4.0, 20 February, 2015 Marine Stewardship Council 2 About the Marine Stewardship Council

More information

Basics of EPC. Training

Basics of EPC. Training Basics of EPC Training Introduction Objectives: - Create awareness of the concepts - Develop technical knowledge - Show benefits of implementation - Explain 5 steps of Implementation 2 Programme Introduction

More information

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the

More information

Warehouse and Production Management with SAP Business One

Warehouse and Production Management with SAP Business One SAP Product Brief SAP s for Small Businesses and Midsize Companies SAP Business One Objectives Warehouse and Production Management with SAP Business One Real-time inventory and production management Real-time

More information

TABLE OF CONTENTS. Page 2 of 6

TABLE OF CONTENTS. Page 2 of 6 Annex I Harmonised maximum and minimum clearing prices for single day-ahead coupling in accordance with Article 41(1) of Commission Regulation (EU) 2015/1222 of 24 July 2015 establishing a guideline on

More information

PRODUCT COMPLAINTS MANAGEMENT. Infosys Handbook For Life Sciences

PRODUCT COMPLAINTS MANAGEMENT. Infosys Handbook For Life Sciences PRODUCT COMPLAINTS MANAGEMENT Infosys Handbook For Life Sciences Table of Contents Introduction 3 Infosys Point of View 4 Success Story - Complaint management for one of the world s top 5 bio-pharmaceutical

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

GS1 STANDARDS IMPLEMENTATION

GS1 STANDARDS IMPLEMENTATION USAID GLOBAL HEALTH SUPPLY CHAIN PROGRAM PROCUREMENT AND SUPPLY MANAGEMENT GS1 STANDARDS IMPLEMENTATION Assessment of the USAID Supplier Base and the Ability of ARTMIS to Support GSI-compliant and Noncompliant

More information